Tag "FAQ"

We are very proud to announce that we have just been granted the license by the HFEA to restart fertility treatments at City Fertility. Everyone at City Fertility has worked hard to ensure that we have new patient pathways in place and that we can provide safe and effective treatment during these challenging times. Thank you all for your patience and support during the lockdown – now let’s create miracles together!

The resumption of fertility treatments is now a step closer now following new guidelines issued by the European Society of Human Reproduction and Embryology (ESHRE).

The recent outbreak of infections with the novel coronavirus has been naturally a source of concern for many of our existing and prospective patients.  Due to the uncertainty as to the course of this outbreak many patients expressed their wish to pursue fertility treatment despite the concern. The following advice is aimed at reducing anxiety and guiding existing and prospective patients so that they can access fertility care safely. 

Preimplantation Genetic Screening (PGS) also known as Preimplantation Genetic Testing - Aneuploidies (PGT-A) refer exactly to the same thing, to the same technology. PGS is an embryo selection tool that can be used in infertility treatment. PGT-A is the newer nomenclature but both PGS and PGT-A are used interchangeably and refer to the exact same thing.